Apex Biotechnology Corp. Logo

Apex Biotechnology Corp. (1733)

TWSE

Currency in TWD
30.15
-0.10 (-0.33%)

Closed

Oct 5, 2026

Day's Range

30.15
30.80

52 wk Range

28.00
38.70

Overview - 1733 - Apex Biotechnology Corp.

Key Statistics

Valuation

Enterprise Value

2.30B

P/E (Trailing)

‪15.76‬

P/E (Forward)

‪15.60‬

PEG Ratio

‪0.57‬

Price / Sales (TTM)

‪1.59‬

Price / Book

‪1.60‬

EV / EBITDA

‪10.42‬

Profitability

Gross Margin

‪33.63%‬

Profit Margin

‪10.19%‬

Operating Margin

‪9.48%‬

Return on Assets

‪4.36%‬

Return on Equity

‪10.43%‬

Ownership

Shares Outstanding

99.95M

Float

60.19M

Held by Insiders

‪37.67%‬

Held by Institutions

‪1.27%‬

Price stats

Beta

‪0.26‬

50-Day Avg

‪31.18‬

200-Day Avg

‪30.14‬

Dividends

Payout Ratio

‪68.78%‬

Frequency

Annual

Analyst Consensus

Buy

1 analysts

News Teaser - 1733 - Apex Biotechnology Corp.

News & Analysis

View all news

Market Cap - 1733 - Apex Biotechnology Corp.

Peers - 1733 - Apex Biotechnology Corp.

Peer Comparison

Compared with companies in Medical Devices listed on TWSE.

Profile Summary - 1733 - Apex Biotechnology Corp.

About

Apex Biotechnology Corp. is a leading player in the life sciences sector, primarily engaged in the research, development, and commercialization of innovative biotechnological solutions. The company focuses on creating advanced therapeutic tools and diagnostic products that address a wide array of health challenges,…

SectorHealthcare
IndustryMedical Devices
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.